Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot
This week’s Phispers is a double bill with news from the last two weeks. Through much of December, the US Food and Drug A...
Impressions : 1461
US Senator seeks “unannounced” FDA inspections; Nektar reports manufacturing issues with lead project
This week in Phispers, we bring you news about Nektar Therapeutics which disclosed declining efficacy of its lead project due t...
Impressions : 2692
FDA releases GDUFA II fee for FY20; Teva to recover settlement charge from execs
This week, the USFDA released its GDUFA II user fee for fiscal 2020.
Unlike last year, when the fees were hiked significantly...
Impressions : 1682
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.